Kanamycin Sulfate CAS 25389-94-0 Raw Materials Powder

CAS: 25389-94-0

MF: C18H38N4O15S

Specification​: 99% min Kanamycin Sulfate

Sample:  Kanamycin Sulfate Powder

Brand: Henrikang

Appearance: White Powder

Storage: Cool Dry Place

Shelf Life: 2 Years

Test Method: HPLC

Kanamycin Sulfate Usage and Synthesis:

Kanamycin monosulfate is white or white powder, odorless, moisture-inducing. Kanamycin monosulfate is soluble in water and almost insoluble in chloroform or ether. Pharmaceutical Ingredients Raw Materials Kanamycin Sulfate Raw Powder CAS 25389-94-0,  Kanamycin Sulfate is an Aminoglycoside compound that is widely used in infections. Kanamycin Sulfate Raw Powder is a  white or off-white powder,  odorless and moisture-attracting.Kanamycin Sulfate CAS 25389-94-0 is used internally for intestinal infections such as  chicken dysentery, typhoid, paratyphoid, avian cholera, livestock and poultry E. coli,  etc. Kanamycin Sulfate Raw Powder is also effective against chronic respiratory disease in chickens,  wheezing disease in pigs and atrophic rhinitis. Kanamycin Sulfate Raw Powder is also effective in chronic respiratory  diseases of chickens, pigs and atrophic rhinitis.

Pharmacokinetics of Kanamycin Sulfate:

Kanamycin sulfate is a powerful antibacterial agent against Gram-negative bacteria such as Escherichia coli, Salmonella, Mycobacterium pneumoniae, Mycobacterium avium, and Bartonella spp. Kanamycin sulfate is also effective against Staphylococcus aureus, Mycobacterium tuberculosis, and Mycobacterium mycobacterium, but not against Pseudomonas aeruginosa, anaerobic bacteria, and Gram-positive bacteria other than Staphylococcus aureus.Kanamycin sulfate is an aminoglycoside compound. It is effective orally and can be administered intravenously and intramuscularly. Kanamycin Sulfate Raw Powder is widely used for infections. Kanamycin Sulfate CAS 25389-94-0 is an aminoglycoside broad-spectrum antibiotic with an antibacterial spectrum similar to that of neomycin.

It is mainly used for serious infections caused by Gram-negative bacteria such as Escherichia coli, Klebsiella, Aspergillus, Pneumobacterium, Enterobacter aerogenes and Shigella. Clinically, it is mainly used for lung infection, urinary tract infection, biliary tract infection sepsis and abdominal cavity infection caused by sensitive bacteria, the latter two are often used in combination with other Antibacterial drugs. It can also be used for the infection of Staphylococcus aureus that is resistant to other antibiotics and sensitive to this product. For the treatment of tuberculosis, this product can be used as a second-line drug.

Clinical Application of Kanamycin Sulfate:

Kanamycin monosulfate is mainly used for respiratory and urinary tract infections and septicemia, mastitis, etc. caused by most Gram-negative bacteria and some drug-resistant Staphylococcus aureus. Kanamycin monosulfate is used internally for intestinal infections such as chicken dysentery, typhoid fever, paratyphoid fever, avian cholera, livestock and poultry E. coli disease, etc. Kanamycin monosulfate is also effective for chronic respiratory disease in chickens, wheezing disease in pigs and atrophic rhinitis, etc. Application of biotechnology to inhibit protein synthesis. For transformation of cells with kanamycin B (neoR, KanR phenotype) resistance gene as a selective agent. There has been a significant increase in resistant strains in recent years, due to the production of aminoglycosidic blunting enzymes by certain bacteria, rendering them inactive for antibacterial activity. Kanamycin has complete cross-resistance with streptomycin and neomycin, and can have partial cross-resistance with other aminoglycosides.